This closed-door Johnson & Johnson Advisory Board will bring together a small group of leaders from across the healthcare ecosystem to gather insights on how health systems, payers, and digital health stakeholders are operationalizing care at scale.
The discussion will examine the current immunology patient journey, identifying areas of friction and opportunities for improvement and innovation. It will also explore how broader developments in policy, technology, care delivery, and patient needs may influence immunology care in the years ahead.
The session is designed to gather independent perspectives and insights from participants to help inform future planning.
